MAPT and Alzheimer disease: The ratio of p-tau/Aβ42 levels is frequently used in AD diagnosis, having a high sensitivity and specificity when used along with the clinical features of the disease, being a tool to differentiate AD from other dementias (Studart Neto et al., 2024).